DOCSLIB.ORG

Expert Peer Review No.2 for Ethylone

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Expert Peer Review No.2 for Ethylone Expert Peer Review No. 2 Agenda Item 4.5: Ethylone Expert Committee on Drug Dependence Thirty-eighth Meeting Geneva, 14-18 November 2016 Expert Peer Review No.2 for Ethylone 1. Comments based on the review report a. Evidence on dependence and abuse potential There are few data available in the published literature at this stage but the existing information suggests that ethylone displays abuse liability. Ethylone substituted fully for the cocaine and methamphetamine stimulus in rats. Data obtained from in vitro studies suggest that ethylone inhibits uptake of norepinephrine, dopamine and serotonin and that it might function as a substrate-type releaser of serotonin, thus, potentially exhibiting some form of ‘hybrid’ character. Data on dependence potential, both in animals and humans, are not available. Case reports and discussions available on drug user forums document that some drug users consumed ethylone. b. Risks to individual and society because of misuse Ten fatalities and a non-fatal intoxication have been reported in the scientific literature with the majority of death cases being linked to violence. A clear cause-and- effect relationship could not be established in all cases. Ethylone does currently not appear to pose a risk to society but is suspected to be restricted to individual users with a history of psychostimulant use in various social settings. c. Magnitude of the problem in countries (misuse, illicit production, smuggling etc) Detailed information about prevalence of ethylone use, illicit production and smuggling are not available. In countries where ethylone is not subject to control, it may be purchased from various sources including Internet retailers, either in the form of branded products or in pure form. In a study reported by researchers in the US, ethylone was detected in 16 out of 34,561 random urine samples collected between 2011 and 2013 (0.05%). Ethylone has been seized in various countries around the globe but increasing numbers of seizures have been reported particularly in the United States (US). Page 1 of 3 Expert Peer Review No. 2 Agenda Item 4.5: Ethylone d. Need of the substance for medical (including veterinary) practice Ethylone is currently not used in medical practice. e. Need of the substance for other purposes (e.g. industrial) Ethylone has currently no industrial application apart from being used for scientific research. f. Measures taken by countries to curb misuse Ethylone is controlled in some countries although it remains unclear how or whether this affected prevalence of ethylone use. g. Impact if this substance is scheduled In the absence of medical or industrial use no discernable impact is expected apart from manageable bureaucratic burden to researchers and laboratories that carry out research. 2. Are there absent data that would be determinative for scheduling? More information about prevalence of ethylone use and the extend of ill-effects comparable to related substances already under international control would be helpful. 3. Other comments or opinions No comments. 4. Expert reviewer’s view on scheduling with rationale The available information currently suggests that ethylone might show some mixed pharmacological features comparable to the new psychoactive substance 4-methyl-N- ethcathinone (4-MEC). Ethylone appears to have the capacity to produce abuse liability, ill-effects and central nervous system stimulation, which is shared by other ring- substituted cathinones under international control such as methylone (Schedule II of the 1971 Convention). The data available at this stage place a challenge on the ability to characterize the extent of a public health and social problem that would warrant the placing of the substance under international control. However, it is recognized that ethylone has been increasingly seized in the US (amongst other countries), possibly reflecting a more recent introduction to the market following control of 4- methylmethcathinone (mephedrone), 3,4-methylenedioxy-N-methcathinone (methylone) Page 2 of 3 Expert Peer Review No. 2 Agenda Item 4.5: Ethylone and 3,4-methylenedioxypyrovalerone (MDPV), respectively. From this perspective, it is recommended to keep ethylone under surveillance. Page 3 of 3 .
Load more

Recommended publications
  • Recommended Methods for the Identification and Analysis of Synthetic Cathinones in Seized Materialsd
    Recommended methods for the Identification and Analysis of Synthetic Cathinones in Seized Materials (Revised and updated) MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES Photo credits:UNODC Photo Library; UNODC/Ioulia Kondratovitch; Alessandro Scotti. Laboratory and Scientific Section UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna Recommended Methods for the Identification and Analysis of Synthetic Cathinones in Seized Materials (Revised and updated) MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES UNITED NATIONS Vienna, 2020 Note Operating and experimental conditions are reproduced from the original reference materials, including unpublished methods, validated and used in selected national laboratories as per the list of references. A number of alternative conditions and substitution of named commercial products may provide comparable results in many cases. However, any modification has to be validated before it is integrated into laboratory routines. ST/NAR/49/REV.1 Original language: English © United Nations, March 2020. All rights reserved, worldwide. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. Mention of names of firms and commercial products does not imply the endorse- ment of the United Nations. This publication has not been formally edited. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. Acknowledgements The Laboratory and Scientific Section of the UNODC (LSS, headed by Dr. Justice Tettey) wishes to express its appreciation and thanks to Dr.
    [Show full text]
  • (19) United States (12) Patent Application Publication (10) Pub
    US 20130289061A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0289061 A1 Bhide et al. (43) Pub. Date: Oct. 31, 2013 (54) METHODS AND COMPOSITIONS TO Publication Classi?cation PREVENT ADDICTION (51) Int. Cl. (71) Applicant: The General Hospital Corporation, A61K 31/485 (2006-01) Boston’ MA (Us) A61K 31/4458 (2006.01) (52) U.S. Cl. (72) Inventors: Pradeep G. Bhide; Peabody, MA (US); CPC """"" " A61K31/485 (201301); ‘4161223011? Jmm‘“ Zhu’ Ansm’ MA. (Us); USPC ......... .. 514/282; 514/317; 514/654; 514/618; Thomas J. Spencer; Carhsle; MA (US); 514/279 Joseph Biederman; Brookline; MA (Us) (57) ABSTRACT Disclosed herein is a method of reducing or preventing the development of aversion to a CNS stimulant in a subject (21) App1_ NO_; 13/924,815 comprising; administering a therapeutic amount of the neu rological stimulant and administering an antagonist of the kappa opioid receptor; to thereby reduce or prevent the devel - . opment of aversion to the CNS stimulant in the subject. Also (22) Flled' Jun‘ 24’ 2013 disclosed is a method of reducing or preventing the develop ment of addiction to a CNS stimulant in a subj ect; comprising; _ _ administering the CNS stimulant and administering a mu Related U‘s‘ Apphcatlon Data opioid receptor antagonist to thereby reduce or prevent the (63) Continuation of application NO 13/389,959, ?led on development of addiction to the CNS stimulant in the subject. Apt 27’ 2012’ ?led as application NO_ PCT/US2010/ Also disclosed are pharmaceutical compositions comprising 045486 on Aug' 13 2010' a central nervous system stimulant and an opioid receptor ’ antagonist.
    [Show full text]
  • 4-Methylethcathinone (4-MEC)
    4‐Methylethcathinone (4‐MEC) Critical Review Report Agenda item 4.15 (R/S)‐ 2‐(Ethylamino)‐1‐(4‐methylphenyl) propan‐1‐one (4‐methyl‐N‐ethylcathinone, 4‐MEC) Expert Committee on Drug Dependence Thirty‐sixth Meeting Geneva, 16‐20 June 2014 36th ECDD (2014) Agenda item 4.15 4‐Methylethcathinone (4‐MEC) Page 2 of 20 36th ECDD (2014) Agenda item 4.15 4‐Methylethcathinone (4‐MEC) Acknowledgements This report has been drafted under the responsibility of the WHO Secretariat, Essential Medicines and Health Products, Policy Access and Rational Use Unit. The WHO Secretariat would like to thank the following people for their contribution in producing this critical review report: Dr Simon Brandt, United Kingdom (literature review and drafting), Dr Caroline Bodenschatz, Switzerland (editing) and Mr David Beran, Switzerland (questionnaire report drafting). Page 3 of 20 36th ECDD (2014) Agenda item 4.15 4‐Methylethcathinone (4‐MEC) Page 4 of 20 36th ECDD (2014) Agenda item 4.15 4‐Methylethcathinone (4‐MEC) Contents Summary.................................................................................................................................................................... 7 1. Substance identification ............................................................................................................................... 8 A. International Nonproprietary Name (INN) ......................................................................................... 8 B. Chemical Abstract Service (CAS) Registry Number ..........................................................................
    [Show full text]
  • AGENDA Friday, September 9, 2016 7:00 A.M
    Needham Board of Health AGENDA Friday, September 9, 2016 7:00 a.m. – 9:00 a.m. Charles River Room – Public Services Administration Building 500 Dedham Avenue, Needham MA 02492 • 7:00 to 7:05 - Welcome & Review of Minutes (July 29 & August 29) • 7:05 to 7:30 - Director and Staff Reports (July & August) • 7:30 to 7:45 - Discussion about Proposed Plastic Bag Ban Christopher Thomas, Needham Resident • 7:45 to 7:50 - Off-Street Drainage Bond Discussion & Vote • 7:50 to 8:00 - Update on Wingate Pool Variance Application * * * * * * * * * * * * * Board of Health Public Hearing • 8:00 to 8:40 - Hearing for Proposed New or Amended BOH Regulations o Body Art o Synthetic Marijuana o Drug Paraphernalia • 8:40 to 8:50 - Board Discussion of Policy Positions • Other Items (Healthy Aging, Water Quality) • Next Meeting Scheduled for Friday October 14, 2016 • Adjournment (Please note that all times are approximate) 1471 Highland Avenue, Needham, MA 02492 781-455-7500 ext 511 (tel); 781-455-0892 (fax) E-mail: [email protected] Web: www.needhamma.gov/health NEEDHAM BOARD OF HEALTH July 29, 2016 MEETING MINUTES PRESENT: Edward V. Cosgrove, PhD, Chair, Jane Fogg, Vice-Chair, M.D., and Stephen Epstein, M.D STAFF: Timothy McDonald, Director, Donna Carmichael, Catherine Delano, Maryanne Dinell, Tara Gurge GUEST: Kevin Mulkern, Aquaknot Pools, Inc., Keith Mulkern, Aquaknot Pools, Inc., David Friedman, Wingate, Paul Humphreys, Michael Tomasello, Callahan, Inc. CONVENE: 7:00 a.m. – Public Services Administration Building (PSAB), 500 Dedham Avenue, Needham MA 02492 DISCUSSION: Call To Order – 7:06 a.m. – Dr. Cosgrove, Chairman APPROVE MINUTES: Upon motion duly made and seconded, the minutes of the BOH meeting of June 17, 2016 were approved as submitted.
    [Show full text]
  • Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither [email protected]
    Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 4-25-2018 Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither [email protected] DOI: 10.25148/etd.FIDC006565 Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Chemistry Commons Recommended Citation Seither, Joshua Zolton, "Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances" (2018). FIU Electronic Theses and Dissertations. 3823. https://digitalcommons.fiu.edu/etd/3823 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida APPLICATION OF HIGH RESOLUTION MASS SPECTROMETRY FOR THE SCREENING AND CONFIRMATION OF NOVEL PSYCHOACTIVE SUBSTANCES A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in CHEMISTRY by Joshua Zolton Seither 2018 To: Dean Michael R. Heithaus College of Arts, Sciences and Education This dissertation, written by Joshua Zolton Seither, and entitled Application of High- Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances, having been approved in respect to style and intellectual content, is referred to you for judgment. We have read this dissertation and recommend that it be approved. _______________________________________ Piero Gardinali _______________________________________ Bruce McCord _______________________________________ DeEtta Mills _______________________________________ Stanislaw Wnuk _______________________________________ Anthony DeCaprio, Major Professor Date of Defense: April 25, 2018 The dissertation of Joshua Zolton Seither is approved.
    [Show full text]
  • Written Witness Statement for U.S. Sentencing Commission's Public
    STATEMENT OF TERRENCE L. BOOS, PH.D. SECTION CHIEF DRUG AND CHEMICAL EVALUATION SECTION DIVERSION CONTROL DIVISION DRUG ENFORCEMENT ADMINISTRATION and CASSANDRA PRIOLEAU, PH.D. DRUG SCIENCE SPECIALIST DRUG AND CHEMICAL EVALUATION SECTION DIVERSION CONTROL DIVISION DRUG ENFORCEMENT ADMINISTRATION - - - BEFORE THE UNITED STATES SENTENCING COMMISSION - - - HEARING ON SENTENCING POLICY FOR SYNTHETIC DRUGS - - - OCTOBER 4, 2017 WASHINGTON, D.C. 1 Introduction New Psychoactive Substances (NPS) are substances trafficked as alternatives to well- studied controlled substances of abuse. NPS have demonstrated adverse health effects such as paranoia, psychosis, and seizures to name a few. Cathinones, cannabinoids, and fentanyl-related substances are the most common NPS drug classes encountered on the illicit drug market, all with negative consequences for the user to include serious injury and death. Our early experience saw substances being introduced from past research efforts in an attempt to evade controls. This has evolved to NPS manufacturers structurally altering substances at a rapid pace with unknown outcomes to targeting specific user populations. These substances represent an unprecedented level of diversity and consequences. Due to clandestine manufacture and unscrupulous trafficking, the user is at great risk. A misconception exists that these substances carry a lower risk of harm In reality, published reports from law enforcement, emergency room physicians and scientists, accompanied with autopsies from medical examiners, have clearly demonstrated the harmful and potentially deadly consequences of using synthetic cathinones. These substances are introduced in an attempt to circumvent drug controls and the recent flood of NPS remains a challenge for law enforcement and public health. The United Nations Office on Drugs and Crime reported over 700 NPS encountered.1 The manufacturers and traffickers make minor changes in the chemical structure of known substances of abuse and maintain the pharmacological effect.
    [Show full text]
  • TOWARDS UNDERSTANDING the MECHANISM of ACTION of ABUSED CATHINONES Rakesh Vekariya Virginia Commonwealth University
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by VCU Scholars Compass Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2012 TOWARDS UNDERSTANDING THE MECHANISM OF ACTION OF ABUSED CATHINONES Rakesh Vekariya Virginia Commonwealth University Follow this and additional works at: http://scholarscompass.vcu.edu/etd Part of the Pharmacy and Pharmaceutical Sciences Commons © The Author Downloaded from http://scholarscompass.vcu.edu/etd/2841 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. © Rakesh H. Vekariya 2012 All Rights Reserved TOWARDS UNDERSTANDING THE MECHANISM OF ACTION OF ABUSED CATHINONES A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University. by Rakesh Harsukhlal Vekariya B. Pharm., Dr. M.G.R. Medical University, Chennai, India 2008 Director: Dr. Richard A. Glennon Professor and Chairman, Department of Medicinal Chemistry Virginia Commonwealth University Richmond, Virginia July, 2012 ii Acknowledgment I would like to thank Dr. Glennon for giving me opportunity to work in his group. His constant support and encouragement throughout my program have been quite helpful. His suggestions and cooperation from the beginning of my project have been very valuable. I would like to thank Dr. Dukat for her guidance and encouragement as well as for creating a friendly work environment. I would like to thank Dr.
    [Show full text]
  • Long-Term Stability of Synthetic Cathinones in Forensic Toxicology Samples Author(S): Sarah Kerrigan, Ph.D., Lindsay Glicksberg, B.S
    NCJRS OFFICE OF JUSTICE PROGRAMS ~ N ATIONAL CRIMINAL JUSTICE REFERENCE SERVICE QJA BJS N/J OJJ[l> OVC SMART ",iiiii~ The author(s) shown below used Federal funding provided by the U.S. Department of Justice to prepare the following resource: Document Title: Long-Term Stability of Synthetic Cathinones in Forensic Toxicology Samples Author(s): Sarah Kerrigan, Ph.D., Lindsay Glicksberg, B.S. Document Number: 251194 Date Received: October 2017 Award Number: 2013-R2-CX-K006 This resource has not been published by the U.S. Department of Justice. This resource is being made publically available through the Office of Justice Programs’ National Criminal Justice Reference Service. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. Contents Abstract........................................................................................................................................... 4 Executive Summary ........................................................................................................................ 6 I. Introduction .......................................................................................................................... 10 Statement of the Problem ........................................................................................................ 10 Literature Citations and Review ................................................................................................ 11 Use and
    [Show full text]
  • The Newest Cathinone Derivatives As Designer Drugs: an Analytical and Toxicological Review
    Forensic Toxicol DOI 10.1007/s11419-017-0385-6 REVIEW ARTICLE The newest cathinone derivatives as designer drugs: an analytical and toxicological review 1,3 3 2 1 Milena Majchrzak • Rafał Celin´ski • Piotr Kus´ • Teresa Kowalska • Mieczysław Sajewicz1 Received: 30 July 2017 / Accepted: 22 August 2017 Ó The Author(s) 2017. This article is an open access publication Abstract Conclusions To our knowledge, this is the most current Purpose Currently, among new psychoactive substances, review presenting new synthetic cathinones. Political cathinone derivatives constitute the biggest group, which authorities should take measures to implement and enforce are mainly classified into N-alkylated, 3,4-methylenedioxy- generic scheduling (comprehensive system) laws to control N-alkylated, N-pyrrolidinyl, and 3,4-methylenedioxy-N- the diversely modified synthetic cathinones. Supplement- pyrrolidinyl derivatives. These derivatives are actively ing the existing databases with new findings can greatly being subjected to minor modifications at the alkyl chains facilitate the efforts of forensic toxicologists. or the aromatic ring to create new synthetic cathinones with the goal of circumventing laws. In this review, the new Keywords New synthetic cathinones Á Designer drugs Á synthetic cathinones that have appeared on the illegal drug NPS Á LC–MS Á GC–MS Á NMR market during the period 2014–2017 are highlighted, and their characterization by gas chromatography–mass spec- trometry and liquid chromatography–tandem mass spec- Introduction trometry is presented. Methods Various key words were used to conduct an Cathinone is one of the biologically active alkaloids found extensive literature search across a number of databases, in the khat shrub (Catha edulis).
    [Show full text]
  • An Approach to the New Psychoactive Drugs Phenomenon
    REVIEW ARTICLE An approach to the new psychoactive drugs phenomenon Helen Dolengevich-Segal,1,2 Beatriz Rodríguez-Salgado,3 Jorge Gómez-Arnau,1 Daniel Sánchez-Mateos4 1 Servicio de Psiquiatría, Hospital ABSTRACT Universitario del Henares. Cosla- da, Madrid. Background. The new psychoactive drugs (NPD) are those that represent a danger to public health and are 2 Fundación Psiformación. Madrid. not prohibited by conventions on international narcotics. The concept also includes new contexts and new 3 Centro de Salud Mental de San Blas. Hospital Universitario routes of consumption as well as novel ways of distribution, notably Internet. The risks associated with NPD Ramón y Cajal. Madrid. consumption are largely unknown to users and to health care providers. Objective. To integrate the exist- 4 Hospital Universitario La Fe. Va- ing evidence regarding the main NPD in terms of description, epidemiology, psychopharmacology, medical lencia. complications and psychoactive effects. Method. To review relevant and updated clinical information on NPD Correspondence: obtained from specialized books and indexed scientific journals (PubMed/Medline, Google Scholar, Scopus), Helen Dolengevich-Segal as well as official documents edited by international organizations dedicated to the epidemiologic analysis Servicio de Psiquiatría, Hospital of drug abuse and Internet websites and forums managed by psychoactive substance users. Results. As- Universitario del Henares. pects of clinical and pharmacological interest are described comprehensively, together with epidemiological Avenida de Marie Curie s/n 28822 Coslada, Madrid, España. data and risks associated to the consumption of the most relevant NPD: synthetic cannabinoids, synthetic Phone: (0034) 91191 - 2852. cathinones, NBOMe series, indoleamines, piperazines, hallucinogenic mushrooms (Psilocybe SP.), synthetic E-mail: [email protected] opioids, plant products (khat, kratom, Salvia divinorum, ayahuasca) and dissociative anesthetics.
    [Show full text]
  • Forensic Chemistry of Substance Misuse a Guide to Drug Control
    Forensic Chemistry of Substance Misuse A Guide to Drug Control Forensic Chemistry of Substance Misuse A Guide to Drug Control L. A. King ISBN: 978-0-85404-178-7 A catalogue record for this book is available from the British Library r L. A. King 2009 All rights reserved Apart from fair dealing for the purposes of research for non-commercial purposes or for private study, criticism or review, as permitted under the Copyright, Designs and Patents Act 1988 and the Copyright and Related Rights Regulations 2003, this publication may not be reproduced, stored or transmitted, in any form or by any means, without the prior permission in writing of The Royal Society of Chemistry or the copyright owner, or in the case of reproduction in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK, or in accordance with the terms of the licences issued by the appropriate Reproduction Rights Organization outside the UK. Enquiries concerning reproduction outside the terms stated here should be sent to The Royal Society of Chemistry at the address printed on this page. Published by The Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge CB4 0WF, UK Registered Charity Number 207890 For further information see our web site at www.rsc.org Preface ‘‘Gold is worse poison to a man’s soul, doing more murders in this loathsome world, than any mortal drug’’ William Shakespeare (Romeo and Juliet) An earlier publication1 described the UK drugs legislation from the viewpoint of a forensic scientist. In the current book, an opportunity has been taken to rearrange and expand the material and improve clarity, to include the changes that have occurred in the past six years, and, more importantly, to widen the scope and the intended audience.
    [Show full text]
  • Determination of Synthetic Cathinones in Urine and Oral Fluid by Liquid
    separations Article Determination of Synthetic Cathinones in Urine and Oral Fluid by Liquid Chromatography High-Resolution Mass Spectrometry and Low-Resolution Mass Spectrometry: A Method Comparison Sergi Pascual-Caro, Francesc Borrull, Carme Aguilar * and Marta Calull Department of Analytical Chemistry and Organic Chemistry, Universitat Rovira i Virgili, Campus Sescelades, Marcel lí Domingo 1, 43007 Tarragona, Spain; [email protected] (S.P.-C.); [email protected] (F.B.); · [email protected] (M.C.) * Correspondence: [email protected]; Tel.: +34-977-558-629 Received: 6 September 2020; Accepted: 26 September 2020; Published: 2 October 2020 Abstract: Synthetic cathinones have become very popular recreational drugs. Therefore, determining them in biological samples is now a matter of concern. In recent years, different methods that have been developed can determine these drugs at low-concentration levels. In general, liquid chromatography mass spectrometry detection plays an important role in these methods and the trend is to use low-resolution and high-resolution mass spectrometry. In this article, for the first time, we compare these two analyzers using an Orbitrap and a triple quadrupole mass spectrometer in order to determine a group of synthetic cathinones in urine and oral fluid samples. For this comparison, we evaluated and compared different parameters: Method detection and quantification limits, linearity, apparent recoveries, matrix effect, repeatability (intra-day), reproducibility (inter-day), and accuracy. Similar results were obtained for the two analyzers for the apparent recoveries and matrix effect. However, triple quadrupole showed higher sensitivity compared to Orbitrap for both urine and oral fluid samples. The quantification limits in urine and the detection limits in saliva were two times lower for triple quadrupole.
    [Show full text]